ArticlebioRxiv : the preprint server for biology2026
NanoHIVSeq: A Long-Read Bioinformatics Pipeline for High-Throughput Processing of HIV Env Sequences.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
High-throughput sequencing of the HIV-1 envelope (Env) gene from viral quasispecies is essential for epidemiology, virus-antibody coevolution studies, and evaluating therapeutics, but the conventional single-genome amplification (SGA) coupled with Sanger sequencing is labor-intensive and low-throughput. Oxford Nanopore Technology (ONT) offers long-read sequencing advantages, but high error rates (1-7%) poses a challenge in identifying biological variants from sequencing artifacts. Without unique molecular identifiers (UMIs), which lose DNA template and add complexity in library preparation, here we introduce NanoHIVSeq, a UMI-free and reference-free bioinformatics pipeline that processes ONT data from bulk Env PCR amplicons through multistep clustering, consensus polishing, indel correction, denoising, and genotyping to recover functional full-length Env variants. By leveraging advanced ONT duplex sequencing technology, NanoHIVSeq was assessed using plasmid env and bulk HIV reservoir datasets, demonstrating high robustness, recovery rate, reproducibility, and accuracy (>99.9% or >Q30) comparable to UMI approaches. Our findings indicated that NanoHIVSeq allows flexible and simplified ONT library preparation for reproducible and efficient Env sequencing especially for large cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.